Philip R Delio MD
Hospital/Neurohospitalist, Vascular Neurology
Neurology Associates of Santa Barbara
Join to view full profile
219 Nogales AveSuite FSanta Barbara, CA 93105
Phone+1 805-682-8153
Fax+1 805-682-5585
Dr. Delio is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Philip Delio, MD, is a neurologist based in Santa Barbara, CA, with subspecialties in hospital neurology as a neurohospitalist and vascular neurology. He completed his residency and fellowship at Stanford University and serves as an adjunct professor at Neurology Associates of Santa Barbara. He has held leadership roles at Santa Barbara Cottage Hospital, including Stroke Program Director and Director of Neurological Services. Dr. Delio is experienced in movement disorders, multiple sclerosis, traumatic brain injury, neuroimmunology, and stroke volume. His research has been widely published and cited in prominent journals. His work has been recognized with honors, including being named a Top Doctor in the LA Area and Southern California by Castle Connolly and receiving the CMS Meaningful Use Stage 1 Certification.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Vascular Neurology, 2000 - 2002- Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1996 - 1999
Santa Barbara Cottage HospitalInternship, Internal Medicine, 1995 - 1996
Georgetown University School of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 1996 - 2028
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PrimeSuite, Greenway Health, LLC, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Greenway PrimeSUITE, Greenway Health, LLC, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Greenway PrimeSUITE, Greenway Health, LLC, 2012, 2014, 2016-2017
Clinical Trials
- Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2) Start of enrollment: 2005 Apr 01
- Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial Start of enrollment: 2003 Aug 01
- GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients Start of enrollment: 2008 Dec 10
Publications & Presentations
PubMed
- 10 citationsAssistance from Automated ASPECTS Software Improves Reader PerformancePhilip R Delio, Matthew L. Wong, Jenny P Tsai, Holly E. Hinson, John McMenamy
Journal of Stroke and Cerebrovascular Diseases. 2021-05-10 - 6 citationsDevelopment of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS).Louis S. Matza, Katie D. Stewart, Glenn Phillips, Philip R Delio, Robert T. Naismith
Multiple Sclerosis and Related Disorders. 2019-06-19 - 5 citationsProsopometamorphopsia and alexia following left splenial corpus callosum infarction: Case report and literature reviewConnor W. McCarty, Gabriel M. Gordon, Aimee M. Walker, Philip Delio, Robert A. Kolarczyk
Eneurologicalsci. 2017-03-01
Press Mentions
Cottage Health Nationally Recognized for Its Commitment to High-Quality Stroke CareAugust 2nd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
